J. Hamann

Markus Bühner, M. Bühner, Werner Kissling, 2012, Health expectations : an international journal of public participation in health care and health policy.

[How do employees of psychiatric hospitals evaluate medical ethical conflicts in coercive measures].

D. Schwerthöffer, J. Hamann, O. Seidl, 2019, Fortschritte der Neurologie-Psychiatrie.

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

S. Leucht, Werner Kissling, K. Wahlbeck, 2003, The Lancet.

Do patients with schizophrenia wish to be involved in decisions about their medical treatment?

S. Leucht, Werner Kissling, J. Hamann, 2005, The American journal of psychiatry.

Shared decision making in psychiatry

S. Leucht, Werner Kissling, J. Hamann, 2003, Acta psychiatrica Scandinavica.

Patient Participation in Medical and Social Decisions in Alzheimer's Disease

M. Bühner, A. Kurz, R. Perneczky, 2011, Journal of the American Geriatrics Society.

Psychiatric decision making in the adoption of a new antipsychotic in Germany.

S. Leucht, Werner Kissling, J. Hamann, 2006, Psychiatric services.

New generation antipsychotics for first episode schizophrenia.

S. Leucht, Werner Kissling, J. Hamann, 2003, The Cochrane database of systematic reviews.

Amisulpride is an “atypical” antipsychotic associated with low weight gain

S. Leucht, Werner Kissling, S. Wagenpfeil, 2004, Psychopharmacology.

Nocebo effects by providing informed consent in shared decision making? Not necessarily: a randomized pilot-trial using an open-label placebo approach

J. Hamann, F. Holzhüter, 2020, BMC Medical Ethics.

Methodological issues in current antipsychotic drug trials.

J. Kane, S. Leucht, S. Heres, 2007, Schizophrenia bulletin.

[Development of a decision aid for participative advance planning for people with dementia and their relatives].

J. Diehl-Schmid, J. Hamann, G. Marckmann, 2020, Der Nervenarzt.

[Inpatient-Equivalent Treatment - Direct Admission vs. Referral from Psychiatric Inpatient Units].

J. Hamann, P. Brieger, Luisa Klocke, 2021, Psychiatrische Praxis.

S2045796020000426jra 1..8

S. Heres, J. Hamann, F. Holzhüter, 2020 .

Patients’ and Psychiatrists’ Perceptions of Clinical Decisions During Schizophrenia Treatment

Werner Kissling, J. Hamann, H. Pfeiffer, 2008, The Journal of nervous and mental disease.

Participation preferences of patients with acute and chronic conditions

Martin Härter, Jürgen Kasper, Christoph Heesen, 2007, Health expectations : an international journal of public participation in health care and health policy.

‘Triadic’ shared decision making in mental health: Experiences and expectations of service users, caregivers and clinicians in Germany

S. Heres, J. Hamann, F. Holzhüter, 2021, Health expectations : an international journal of public participation in health care and health policy.

Why and How Family Caregivers Should Participate in Shared Decision Making in Mental Health.

S. Heres, J. Hamann, 2019, Psychiatric services.

How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?

S. Leucht, S. Heres, Werner Kissling, 2010, European Neuropsychopharmacology.

Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysis

Florian Wickelmaier, S. Heres, Werner Kissling, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Supporting return to work after psychiatric hospitalization—A cluster randomized study (RETURN-study)

P. Falkai, M. Bühner, A. Hasan, 2023, European Psychiatry.

How do employees currently admitted to acute psychiatric inpatient units rate their psychosocial working conditions with the COPSOQ (Copenhagen Psychosocial Questionnaire)

J. Hamann, P. Brieger, L. Riedl, 2023, The International journal of social psychiatry.

Over-the-Counter-Drugs for the Treatment of Mood and Anxiety Disorders – The Views of German Pharmacists

Hans Förstl, K. Linde, J. Hamann, 2014, Pharmacopsychiatry.

Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database

Werner Kissling, J. Hamann, A. Ruppert, 2003, International clinical psychopharmacology.

Complaint-management in psychiatry – a nationwide survey in Germany

Werner Kissling, J. Hamann, R. Mendel, 2007, Psychiatrische Praxis.

Self-Stigma and Consumer Participation in Shared Decision Making in Mental Health Services.

M. Bühner, N. Rüsch, J. Hamann, 2017, Psychiatric services.

Barriers and facilitators of shared decision making in acutely ill inpatients with schizophrenia—Qualitative findings from the intervention group of a randomised‐controlled trial

S. Heres, J. Hamann, F. Holzhüter, 2021, Health expectations : an international journal of public participation in health care and health policy.

S2045796020000505jra 1..7

S. Heres, B. Haller, J. Hamann, 2020 .

Shared decision making PLUS – a cluster-randomized trial with inpatients suffering from schizophrenia (SDM-PLUS)

S. Heres, L. Stecher, J. Hamann, 2017, BMC Psychiatry.

What can patients do to facilitate shared decision making? A qualitative study of patients with depression or schizophrenia and psychiatrists

M. Bühner, M. Albus, J. Hamann, 2015, Social Psychiatry and Psychiatric Epidemiology.

Trends and perspectives of shared decision-making in schizophrenia and related disorders

Werner Kissling, J. Hamann, R. Beitinger, 2014, Current opinion in psychiatry.

"How to speak to your psychiatrist": shared decision-making training for inpatients with schizophrenia.

S. Leucht, Werner Kissling, J. Hamann, 2011, Psychiatric services.

Effects of a question prompt sheet on active patient behaviour: A randomized controlled trial with depressed outpatients

Petra Wolf, Werner Kissling, J. Hamann, 2014, The International journal of social psychiatry.

Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medication

S. Heres, Werner Kissling, J. Hamann, 2014, European Neuropsychopharmacology.

Clinical implications of Brief Psychiatric Rating Scale scores.

Stefan Leucht, J. Kane, S. Leucht, 2005, The British journal of psychiatry : the journal of mental science.

Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders.

Werner Kissling, I. Spellmann, J. Hamann, 2014, Psychiatric services.

Which medical and social decision topics are important after early diagnosis of Alzheimer’s Disease from the perspectives of people with Alzheimer’s Disease, spouses and professionals?

A. Kurz, R. Perneczky, J. Hamann, 2016, BMC Research Notes.

Shared decision making, aggression, and coercion in inpatients with schizophrenia

S. Heres, J. Hamann, P. Brieger, 2020, European Psychiatry.

Clinical Decision-Making During Psychiatric Ward Rounds

S. Heres, J. Hamann, F. Holzhüter, 2021, Frontiers in Psychiatry.

Linking the PANSS, BPRS, and CGI: Clinical Implications

J. Kane, S. Leucht, Werner Kissling, 2006, Neuropsychopharmacology.

Early-Onset Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and Extended

J. Kane, S. Leucht, Werner Kissling, 2005, Biological Psychiatry.

Do physicians’ recommendations pull patients away from their preferred treatment options?

M. Bühner, D. Frey, Werner Kissling, 2012, Health expectations : an international journal of public participation in health care and health policy.

How do patients from eastern and western Germany compare with regard to their preferences for shared decision making?

G. Elwyn, Werner Kissling, K. Linde, 2012, European journal of public health.

Informing the development of a decision aid: Expectations and wishes from service users and psychiatrists towards a decision aid for antipsychotics in the inpatient setting

S. Leucht, S. Heres, J. Hamann, 2023, Health expectations : an international journal of public participation in health care and health policy.

How should patient decision aids for schizophrenia treatment be designed? - A scoping review

S. Leucht, J. Hamann, S. Siafis, 2023, Schizophrenia Research.

Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics.

M. Ziegler, M. Bühner, S. Heres, 2009, Psychiatric services.

Wer nimmt sich das Leben? Ergebnisse einer psychologischen Autopsiestudie im Allgäu basierend auf Polizeiakten

J. Hamann, P. Brieger, Beatrix Kaps, 2020, Psychiatrische Praxis.

Differences between suicide note leavers and other suicides: A German psychological autopsy study.

S. Menzel, J. Hamann, P. Brieger, 2021, Journal of psychiatric research.

Patient participation in antipsychotic drug choice decisions

Werner Kissling, F. Schmitz, J. Hamann, 2010, Psychiatry Research.

Clinical implications of Brief Psychiatric Rating Clinical implications of Brief Psychiatric Rating

J. Kane, S. Leucht, Werner Kissling, 2005 .

Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.

S. Leucht, Werner Kissling, J. Hamann, 2003, Pharmacopsychiatry.

Are the Second-generation Antipsychotics Cost-effective? A Critical Review on the Background of Different Health Systems

S. Leucht, Werner Kissling, J. Hamann, 2003, Pharmacopsychiatry.

The cost-utility of a return-to-work intervention in comparison to routine care for patients with mental disorders in Germany: Results from the RETURN project

M. Bühner, R. Kilian, J. Hamann, 2023, European Psychiatry.

Drowning in Numbers–what Psychiatrists Mean when Talking to Patients about Probabilities of Risks and Benefits of Medication

M. Bühner, S. Leucht, Werner Kissling, 2010, European Psychiatry.

Pretrial medication bias in randomized antipsychotic drug trials.

S. Leucht, S. Heres, Werner Kissling, 2007, The American journal of psychiatry.

A “Mental-Health-at-the-Workplace” Educational Workshop Reduces Managers' Stigma Toward Depression

Werner Kissling, C. Rummel-Kluge, J. Hamann, 2016, The Journal of nervous and mental disease.

[Mental health at the workplace - the view of companies].

Werner Kissling, J. Hamann, R. Mendel, 2013, Psychiatrische Praxis.

[Effects of a shared decision making model in psychiatric and neurologic practice].

Werner Kissling, C. Heesen, M. Härter, 2006, Der Nervenarzt.

[Return to Work after Mental Disorders - A Scoping Review].

J. Hamann, P. Brieger, Daniel Blank, 2020, Psychiatrische Praxis.

[From Theory into Practice - Early Experiences with Home Treatment in Munich, Germany].

J. Hamann, P. Brieger, Eva Ketisch, 2020, Psychiatrische Praxis.

Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia.

S. Leucht, Werner Kissling, J. Hamann, 2005, Psychiatric services.

Language bias in neuroscience—is the Tower of Babel located in Germany?

S. Leucht, S. Heres, Werner Kissling, 2004, European Psychiatry.

Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysis

Florian Wickelmaier, S. Heres, Werner Kissling, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

How do patients from eastern and western Germany compare with regard to their preferences for shared decision making?

G. Elwyn, Werner Kissling, K. Linde, 2012, European journal of public health.

Confirmation bias: why psychiatrists stick to wrong preliminary diagnoses

J. Kane, S. Leucht, K. Maino, 2011, Psychological Medicine.

Is interpersonal fairness in the doctor-patient relationship associated with long-term compliance in patients with schizophrenia?

Werner Kissling, E. Jonas, J. Hamann, 2013 .

How psychiatrists inform themselves and their patients about risks and benefits of antipsychotic treatment

D. Frey, S. Heres, Werner Kissling, 2009, Acta psychiatrica Scandinavica.